Popular on TelAve
- Democracy at Work & The Left Forum Presents Seminar with Professor Richard D. Wolff based on "Understanding Capitalism" - 175
- Human Resources Strategy Forum Celebrates 30 Years Empowering Leaders, Shaping the Next Generation of HR Innovators - 117
- Self-eSTEM Celebrates A Decade of Empowering BIPOC Women & Girls in STEM
- Voices Rising Festival Celebrates Diversity in E. Islip, GRAMMY Governor LACHI performs!
- Allegiant Management Group Launches New Website Following Recent Rebranding
- The Enchanting Tree-Talking Wizards Are Back!
- Pikmykid School Messaging Empowering Schools Across the United States
- HandicapMD.com Revolutionizes Access to Handicap Placards in New York
- Leading Arizona Real Estate Team Rebrands to SPACE, Marking a New Era in Real Estate Innovation
- AuthuSign Launches Mobile Web App, Empowering Users to Sign Documents on the Go
Similar on TelAve
- 5 Questions to Always Ask Roofing Companies in Memphis Before Hiring Them
- Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader: Heartbeam: Stock Symbol: BEAT
- ConverzAI Accelerates Industry Transformation with Groundbreaking AI-Powered Virtual Recruiters
- Cummings Graduate Institute for Behavioral Health Studies Celebrates 10 Years of Excellence in Integrated Behavioral Healthcare Education
- Significant Leaps Redefining Digital Commerce Connecting Merchants & Shoppers Rewarding Customers with Instant Cash Rebates (Stock Symbol: STBX)
- K2 Integrity Appoints Justina Rousseau Senior Managing Director for Financial Crimes Risk Management Advisory Practice
- Get an Online Handicap Parking Placard in New York City: HandicapMD.com Simplifies Access to Handicap Placards
- 5 Questions to Ask a Commercial Window Cleaning Company in Los Angeles, CA Before Hiring Them
- Breaking Ground and Forging Partnerships: Recap of Paper Industry's Participation in Drupa Expo and Future Endeavors
Powerful Leadership Transition to Optimize Highly Promising AI Platform RenovaroCube for Multi-Cancer Early Detection & Monitoring: Stock Symbol: RENB
TelAve News/10843821
Supermajority of RENB Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full Five-Member Slate.
LOS ANGELES - TelAve -- Realignment to Optimize & Commercialize RenovaroCube, Disruptive AI Platform for Multi-omics Diagnostics for Cancer Early Detection and Patient Monitoring from Liquid Biopsies.
New Board Encompass Seasoned Veterans from Capital Markets, Governance, AI, Biotechnology, Cancer Detection and Treatment.
Restructuring to Accelerate Growth, Commercialization, Access to Strategic Capital and Create Long-Term Value for Shareholders.
Renovaro, Inc. (Stock Symbol: RENB) aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RENB includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.
RENB RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective.
Strategic Restructuring and Leadership Transition
On October 16th RENB announced a strategic restructuring and leadership transition of senior management and the Board of Directors to realign resources focused on the Company's AI Platform, RenovaroCube for multi-cancer early detection and patient monitoring. The RENB Board, with the support of a supermajority of shareholders, appointed David Weinstein as director and new CEO and four new directors – Maurice van Tilburg, Chairman, Douglas Calder, James A. McNulty CPA, and Mark A. Collins PhD.
More on TelAve News
RENB new leadership led by David Weinstein, CEO, renowned senior Wall Street executive with 39 years in banking & analyst roles, recognized for developing dynamic growth strategies for a broad range of private and public companies with a focus on maximizing the value of innovative life science platforms.
RENB CEO David Weinstein commented, "The new five-member board is led by the new Chairman, Maurice van Tilburg, former CEO of Euronext Amsterdam and Director at the Netherlands National Growth Fund". Maurice brings a wealth of experience in Corporate Governance, operations, and product development critical to executing on RenoVision 2.0. Moreover, he is based in Amsterdam to assist our AI driven early cancer detection program at RenovaroCube."
Mr. Weinstein continued, "The rest of our experienced Board of Directors includes: James A. McNulty: after a 26 year-career as founder of three CPA firms, Mr. McNulty has served as CFO of several publicly traded Biopharmaceutical companies including 15 years at BioDelivery Sciences International.Douglas W. Calder: For the last 24 years Mr. Calder has served in a number of senior life science executive roles with a focus on cancer immunotherapy and is currently co-founder and president of Vycellix Inc., a company developing cell-based therapeutics, headquartered in Tampa, Florida at the Moffitt Cancer Center with scientific operations in Stockholm, Sweden on the Karolinska Institute campus.Mark A Collins, PhD: co-founded three companies in drug discovery, artificial intelligence, and the software space. Mark has strong knowledge of commercializing products and platforms in oncology diagnostics."
RENB Revitalized Commitment to "Ambitious Innovation" Includes:
1) Strategic Asset Review & Pipeline Prioritization.
More on TelAve News
2) Commitment to Develop RENB RenovaroCube as Best-in-Class Platform, while Securing World-Class Enabling Partnerships (Corporate & Academic).
3) Optimizing, Enhancing & Accelerating Cell Therapy Pipeline Clinical Advancement.
4) Financial Initiatives to Ensure the RENB Balance Sheet Strength in Tandem with Fiscal Responsibility including Strict Budget Discipline.
5) Synchronizing All Aspects of RRNB Business Units to Yield Maximum Benefits to Patients and Shareholders.
Independent Expert Assessment Validates RENB RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
Assessment by specialist AI team from "PersonalAIze" Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform
On September 19th RENB announced thart PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube's advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which the RENB RenovaroCube is based.
Advancing AI models by leveraging the latest state-of-the-art techniques.
Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.
Company Websites: www.renovarobio.com and https://www.compasslivemedia.com/renb/
Media Contact
Company Name: Renovaro Inc.
Contact Person: David Weinstein, CEO
Email: ir@renovarobio.com
Phone: 732-780-5036
Home Country: United States
Disclaimer and Disclosure: www.aibrandnetwork.com
New Board Encompass Seasoned Veterans from Capital Markets, Governance, AI, Biotechnology, Cancer Detection and Treatment.
Restructuring to Accelerate Growth, Commercialization, Access to Strategic Capital and Create Long-Term Value for Shareholders.
Renovaro, Inc. (Stock Symbol: RENB) aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RENB includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.
RENB RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective.
Strategic Restructuring and Leadership Transition
On October 16th RENB announced a strategic restructuring and leadership transition of senior management and the Board of Directors to realign resources focused on the Company's AI Platform, RenovaroCube for multi-cancer early detection and patient monitoring. The RENB Board, with the support of a supermajority of shareholders, appointed David Weinstein as director and new CEO and four new directors – Maurice van Tilburg, Chairman, Douglas Calder, James A. McNulty CPA, and Mark A. Collins PhD.
More on TelAve News
- ConverzAI Accelerates Industry Transformation with Groundbreaking AI-Powered Virtual Recruiters
- Cummings Graduate Institute for Behavioral Health Studies Celebrates 10 Years of Excellence in Integrated Behavioral Healthcare Education
- Significant Leaps Redefining Digital Commerce Connecting Merchants & Shoppers Rewarding Customers with Instant Cash Rebates (Stock Symbol: STBX)
- Michele Vreeland Explores the Supernatural with Haunting New Single 'Soul Collector,' Releasing October 25th, Just in Time for Halloween
- Megabits Per Second (Mbps) Explained: Speed Test For WiFi Shares Essential Insights for Boosting Internet Performance
RENB new leadership led by David Weinstein, CEO, renowned senior Wall Street executive with 39 years in banking & analyst roles, recognized for developing dynamic growth strategies for a broad range of private and public companies with a focus on maximizing the value of innovative life science platforms.
RENB CEO David Weinstein commented, "The new five-member board is led by the new Chairman, Maurice van Tilburg, former CEO of Euronext Amsterdam and Director at the Netherlands National Growth Fund". Maurice brings a wealth of experience in Corporate Governance, operations, and product development critical to executing on RenoVision 2.0. Moreover, he is based in Amsterdam to assist our AI driven early cancer detection program at RenovaroCube."
Mr. Weinstein continued, "The rest of our experienced Board of Directors includes: James A. McNulty: after a 26 year-career as founder of three CPA firms, Mr. McNulty has served as CFO of several publicly traded Biopharmaceutical companies including 15 years at BioDelivery Sciences International.Douglas W. Calder: For the last 24 years Mr. Calder has served in a number of senior life science executive roles with a focus on cancer immunotherapy and is currently co-founder and president of Vycellix Inc., a company developing cell-based therapeutics, headquartered in Tampa, Florida at the Moffitt Cancer Center with scientific operations in Stockholm, Sweden on the Karolinska Institute campus.Mark A Collins, PhD: co-founded three companies in drug discovery, artificial intelligence, and the software space. Mark has strong knowledge of commercializing products and platforms in oncology diagnostics."
RENB Revitalized Commitment to "Ambitious Innovation" Includes:
1) Strategic Asset Review & Pipeline Prioritization.
More on TelAve News
- Jude Madrigal releases his first children's book, "The Trick-or-Treat Tree and the First Halloween."
- Lend a Hand Uganda-USA Hosts Its 10th Annual Poker Casino Night and Wine Tasting Fundraiser to Support Ugandan Children's Lunch Program
- Vantiva and Ann Mason Care Launch Innovative Remote-Enabled Home Care Service in the UK powered by the HomeSightTM Connected Care Solution
- K2 Integrity Appoints Justina Rousseau Senior Managing Director for Financial Crimes Risk Management Advisory Practice
- Get an Online Handicap Parking Placard in New York City: HandicapMD.com Simplifies Access to Handicap Placards
2) Commitment to Develop RENB RenovaroCube as Best-in-Class Platform, while Securing World-Class Enabling Partnerships (Corporate & Academic).
3) Optimizing, Enhancing & Accelerating Cell Therapy Pipeline Clinical Advancement.
4) Financial Initiatives to Ensure the RENB Balance Sheet Strength in Tandem with Fiscal Responsibility including Strict Budget Discipline.
5) Synchronizing All Aspects of RRNB Business Units to Yield Maximum Benefits to Patients and Shareholders.
Independent Expert Assessment Validates RENB RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
Assessment by specialist AI team from "PersonalAIze" Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform
On September 19th RENB announced thart PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube's advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which the RENB RenovaroCube is based.
Advancing AI models by leveraging the latest state-of-the-art techniques.
Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.
Company Websites: www.renovarobio.com and https://www.compasslivemedia.com/renb/
Media Contact
Company Name: Renovaro Inc.
Contact Person: David Weinstein, CEO
Email: ir@renovarobio.com
Phone: 732-780-5036
Home Country: United States
Disclaimer and Disclosure: www.aibrandnetwork.com
Source: Corporate Ads
0 Comments
Latest on TelAve News
- ALL Mainnet Launches AUSDT Stablecoin onto the global arena
- The Giving Edge: Is Leveraging Outrageous Kindness the Missing Link for Corporate ROI?
- One Of The Largest Native American Burial Sites In The United States Moves A Step Closer To National Recognition
- Cummings Graduate Institute for Behavioral Health Studies Announces New Book: Integrated Behavioral Health: Applying the Biodyne Mindset in Healthcare
- SureFlow to Showcase AI and Eco-Technology Energy Management Solutions at GITEX 2024
- Smart Merchant Solution goes BLUU to strengthen its position in the Point of Sale (POS) Solutions and Payments Processing Sector
- Local SF Conservatory Pre-College Student Selected to Perform at Carnegie Hall
- Origination of Prince Oak's new alias and reasons of his change — the Eurasian Prince's newest nominal label is "Papa Eurasia"
- Ageless Evolution Summit Brings Global Experts Together to Redefine Wellness, Longevity
- Anaptyx Selected Top Wireless Internet Service Provider (WISP) 2024
- Bug Busters Celebrates 40 Years in the Pest Control Industry
- National Minority Health Association and Cell-Ed Announce Upcoming Webinar: Empowering Caregivers Through Innovative Training Programs
- BroadSource Secures Win in Cisco Partner Innovation Challenge
- Free 6-Month Premium Matrimonial Membership Now Available on IndoMarry.com
- NEMTAC Announces Public Comment Period for the NEMTAC 3001-202X Transportation Specialist Education Draft Standard
- Dr. Stephen Shainbart, PHD, Highlights 5 Reasons to Discuss Family Therapy and Couples Counseling in Buffalo, NY
- Restoration Specialists Celebrates a Successful 2024 and Strong Q4
- Purple Union C-Murder Supporting Angola Prisoners in Their Fight for Basic Human Rights Through Labor Strike
- OpsVeda Is Now Available Through AWS Marketplace
- Circumference Group Acquires Majority Stake in Visionary Integration Professionals